| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 6,742.32 | 6,450.57 | 6,168.44 | 4,248.24 |
yoy growth (%) | 4.52 | 4.57 | 45.19 | -7.49 |
Raw materials | -1,907.5 | -1,669.67 | -1,637.45 | -1,115.69 |
As % of sales | 28.29 | 25.88 | 26.54 | 26.26 |
Employee costs | -1,097.93 | -1,097.12 | -1,061.76 | -826.07 |
As % of sales | 16.28 | 17 | 17.21 | 19.44 |
Other costs | -1,636.13 | -1,492.05 | -1,552.24 | -1,399.1 |
As % of sales (Other Cost) | 24.26 | 23.13 | 25.16 | 32.93 |
Operating profit | 2,100.76 | 2,191.73 | 1,916.99 | 907.38 |
OPM | 31.15 | 33.97 | 31.07 | 21.35 |
Depreciation | -602.43 | -609.84 | -606.66 | -383.88 |
Interest expense | -236.29 | -334.12 | -430.49 | -293.68 |
Other income | 204.17 | 118.34 | 236.93 | 332.31 |
Profit before tax | 1,466.21 | 1,366.11 | 1,116.77 | 562.13 |
Taxes | -474.76 | -228.26 | -178.26 | -80.09 |
Tax rate | -32.38 | -16.7 | -15.96 | -14.24 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | 991.45 | 1,137.85 | 938.51 | 482.04 |
Exceptional items | 0 | 0 | 0 | 0 |
Net profit | 991.45 | 1,137.85 | 938.51 | 482.04 |
yoy growth (%) | -12.86 | 21.24 | 94.69 | -43.56 |
NPM | 14.7 | 17.63 | 15.21 | 11.34 |
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.
The company announced that its India business grew by 10% year on year in the June quarter, with sales rising to ₹1,635 Crore from ₹1,426 Crore in Q1 FY24.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Bajaj Finance, Vedanta, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
